511MO A phase I study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with advanced non-small cell lung cancer (NSCLC)J. Feng,M. Shi, J. Chen,K. Li,X. Li, M. Sun, B. Li, G. Wen,Y. Fang, X. Min, L. Lin, Y. Liu,Q. Wang, S. Lu, B. Zhu,Y-K. Shi, H. Yu,Y. Peng,F. Liang, P. LiuAnnals of Oncology（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
